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Utilization of Blood Culture in South Asia for the 
Diagnosis and Treatment of Febrile Illness
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Foundation for the Centers for Disease Control and Prevention, Atlanta, Georgia, USA, and 9Department of Medicine, Division of Infectious Diseases, University of Toronto, Toronto, Ontario, Canada
Background. Blood culture is the current standard for diagnosing bacteremic illnesses, yet it is not clear how physicians in many 
low- and middle-income countries utilize blood culture for diagnostic purposes and to inform treatment decisions. 
Methods. We screened suspected enteric fever cases from 6 hospitals in Bangladesh, Nepal, and Pakistan, and enrolled patients 
if blood culture was prescribed by the treating physician. We used generalized additive regression models to analyze the probability 
of receiving blood culture by age, and linear regression models to analyze changes by month to the proportion of febrile cases pre-
scribed a blood culture compared with the burden of febrile illness, stratified by hospital. We used logistic regression to analyze pre-
dictors for receiving antibiotics empirically. We descriptively reviewed changes in antibiotic therapy by susceptibility patterns and 
coverage, stratified by country. 
Results. We screened 30 809 outpatients resulting in 1819 enteric fever cases; 1935 additional cases were enrolled from other 
hospital locations. Younger outpatients were less likely to receive a blood culture. The association between the number of febrile 
outpatients and the proportion prescribed blood culture varied by hospital. Antibiotics prescribed empirically were associated with 
severity and provisional diagnoses, but 31% (1147/3754) of enteric fever cases were not covered by initial therapy; this was highest in 
Pakistan (50%) as many isolates were resistant to cephalosporins, which were commonly prescribed empirically. 
Conclusions. Understanding hospital-level communication between laboratories and physicians may improve patient care and 
timeliness of appropriate antibiotics, which is important considering the rise of antimicrobial resistance.
Keywords.  blood culture; fever; typhoid; South Asia; antimicrobial resistance.
Blood culture is the currently accepted standard for diagnosing 
suspected cases of bacteremia. In most high-income countries, 
blood cultures are routinely drawn for febrile patients when 
bacteremia is suspected. However, in resource-constrained set-
tings, clinicians may choose to treat patients with antibiotics 
empirically, in part due to limited or absent laboratory capacity 
[1, 2]. In the current era of increasing antimicrobial resistance 
(AMR), particularly in South Asia [3, 4], blood cultures are an 
increasingly important tool to guide appropriate treatment and 
promote antimicrobial stewardship [5].
With a global action plan set forth by the World Health 
Organization to combat AMR [6], and an awareness of how 
AMR affects achieving Sustainable Development Goals 
[7], a better understanding of the interaction between 
clinician decision-making, blood culture use, and prescribed 
antimicrobials can help guide interventions to address AMR in 
South Asia. Antimicrobial susceptibility results from blood cul-
tures can help drive clinical decisions, including choosing an 
appropriate antibiotic if one is required [2]. However, prior re-
search demonstrates underutilization of blood cultures among 
febrile patients in low- and middle-income countries (LMICs) 
[8], and among patients ultimately found to be bacteremic [9]. 
In many LMICs, blood cultures might not be ordered for fe-
brile cases when bacteremia is suspected for several reasons, in-
cluding low sensitivity of the assay [10], high cost, and logistical 
issues related to patient follow-up. Indeed, the long duration to 
available results might dissuade clinicians from ordering cul-
tures in settings such as outpatient departments, where many 
patients might not return or be contactable for follow-up.
In addition to diagnostic testing, clinicians might not re-
vise patient therapy in response to culture results [9], though 
data on this topic are lacking in LMICs. In South Asia, the 
burden of resistant organisms is high among gram-negative 
organisms [11–13], including organisms that cause enteric 
fever (Salmonella enteria serotypes Typhi and Paratyphi A) 
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spread of extensively drug-resistant (XDR) Salmonella Typhi, 
a strain resistant to 5 different classes of antimicrobials [16, 
17]. However, it is unclear if there have been meaningful 
changes to clinician behavior in the context of an increasing 
burden of antimicrobial resistance.
This study evaluated data from the Surveillance for Enteric 
Fever in Asia Project (SEAP) that characterized the burden of 
enteric fever in Bangladesh, Nepal, and Pakistan, including in-
cidence rates, disease severity, and economic burden [18]. Here, 
we report on the utilization of blood culture for clinical deci-
sion-making related to the diagnosis and treatment of potential 
and confirmed bloodstream infections in these 3 South Asian 
countries; this included assessing if demographic characteris-
tics and febrile burden at the hospital predicted prescription of 
blood cultures, predictors for receiving antibiotics before avail-
able blood culture results, and alterations to treatment regimen 
based on blood culture results, as well as whether identification 




SEAP was a prospective cohort study in hospitals in Bangladesh, 
Nepal, and Pakistan [18]. Prospective recruitment occurred 
from September 2016 to September 2019. This article presents 
2 years of data from April 2017 through March 2019.
Study Sites
Patients were recruited from inpatient, outpatient (in-
cluding emergency departments), and hospital laboratories 
in 6 hospitals: Aga Khan University Hospital and Kharadar 
General Hospital (Pakistan); Dhaka Shishu Hospital and 
Shishu Sasthya Foundation Hospital (Bangladesh); Dhulikhel 
Hospital and Kathmandu Medical College Hospital (Nepal) 
(Table  1). More information on the sites is available in this 
supplement [19–21].
Inclusion Criteria
For prospective surveillance, patients were screened for inclu-
sion criteria based on the point of contact with SEAP staff. At 
outpatient clinics and emergency departments, patients were 
screened for ≥3 days of fever and residence within the hospital 
catchment area, established by review of enteric fever patients’ 
addresses [22]. At inpatient wards, patients were screened for 
clinical suspicion or laboratory-confirmed diagnosis of en-
teric fever, regardless of residential address and if not enrolled 
at outpatient. Among those meeting SEAP inclusion criteria, 
study staff determined if the attending physician prescribed a 
blood culture. Per study protocol, only patients who had been 
prescribed a blood culture, and/or who agreed to provide one, 
were considered eligible for enrollment; patients received a 
blood draw shortly after enrollment (if not already provided). 
Patients were also enrolled retrospectively from laboratories if 
Salmonella Typhi or Salmonella Paratyphi A infection was con-
firmed by blood culture, regardless of residential address, if the 
patient was not already enrolled from outpatient or inpatient 
wards.
Data Collection
SEAP staff collected visit date, age, and sex information on all 
patients meeting the inclusion criteria. If those patients were 
prescribed a blood culture and gave consent for enrollment, 
patients were interviewed about clinical information such as 
symptoms, disease severity, and previous care-seeking be-
havior. Medical records were also reviewed to obtain data on 
diagnoses, medication types and dates, laboratory analyses, and 
Table 1. Site Characteristics and Overall Descriptive Statistics of Recruited Patients, Surveillance for Enteric Fever in Asia Project (SEAP)—Bangladesh, 








Kathmandu Medical College 
and Teaching Hospital






Site location Dhaka` Dhaka Dhulikhel Kathmandu Karachi
Catchment area population 1 million 1 million 84 000 448 000 1.2 million 687 000
Population served Urban Urban Peri-urban/Rural Urban Urban Urban
Population recruited Pediatric (≤15) Pediatric (≤15) Pediatric and adult Pediatric and adult Pediatric and adult Pediatric 
and adult
Level of adherence to re-
cruitment protocol
Full Partial Full Full Partial Partial
Patients recruited at out-
patient
6949 12 187 1631 2020 4597 3425
 Median age, (IQR) 3 (1.7–6) 3 (1.5–6) 20 (6–38) 20 (10–31) 20 (3–39) 4 (1.6–11)
 Male sex, n (%) 3771 (54) 6741 (55) 902 (55) 1212 (60) 2414 (53) 1879 (55)
 Prescribed blood culture, 
n (%)
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hospitalization. All data were entered into a custom, SQL-based 
system using standardized tools.
Laboratory Analysis
All sites utilized BACTEC™ (Becton Dickinson, Baltimore, 
MD) to assess for bacterial pathogens in blood collected from 
participants. Susceptibility patterns of Salmonella Typhi and 
Salmonella Paratyphi A isolates were assessed via disk diffusion 
using Clinical & Laboratory Standards Institute guidelines [23].
Statistical Analysis
We separated our analyses based on adherence to the re-
cruitment protocol (Figure  1). At Dhaka Shishu Hospital 
(Bangladesh), all outpatients meeting the inclusion criteria 
were prescribed a blood culture. At both hospitals in Nepal 
(Dhulikhel Hospital and Kathmandu Medical College and 
Teaching Hospital), the local Institutional Review Board per-
mitted SEAP staff to ask patients who had not been prescribed 
blood culture by physicians if they would consent to provide a 
blood sample. Therefore, Dhaka Shishu Hospital (Bangladesh), 
Dhulikhel Hospital (Nepal), and Kathmandu Medical College 
and Teaching Hospital (Nepal) had full adherence to SEAP 
recruitment protocol. At Shishu Sasthya Foundation Hospital 
(Bangladesh), Aga Khan University Hospital (Pakistan), and 
Kharadar General Hospital (Pakistan), physicians only pre-
scribed blood culture based on clinical suspicion, therefore 
did not fully adhere to the SEAP recruitment protocol (subse-
quently referred to as “partial adherence”).
Since all recruited patients at full adherence hospitals were 
prescribed a blood culture, we utilized data from partial ad-
herence hospitals for the analyses on prescription of blood 
culture. To evaluate if the physician’s decision-making was 
associated with age of the patient, we used generalized addi-
tive regression models stratified by hospital. We also assessed 
whether physicians’ practice for prescribing blood cultures 
was associated with current and/or prior febrile illness burden 
in the outpatient wards. We used linear regression models to 
estimate the association between the proportion of febrile 
patients prescribed a blood culture in a calendar month and 
the number of febrile cases recruited at outpatient wards in 
the same month. We then created lagged febrile case burden 
variables using the number of febrile cases in the previous 
1–5 months and assessed in 5 additional models, stratified by 
hospital (18 total models).
Figure 1. Flow of data for analysis, Surveillance for Enteric Fever in Asia Project (SEAP)—Bangladesh, Nepal and Pakistan, April 2017–March 2019. Note: Full adher-
ence = Attending physicians prescribed a blood culture for outpatients meeting the inclusion criteria (3 or more days of fever and residence within the hospital catchment 
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To analyze clinical decision-making in regards to treatment 
before and after blood culture results, we used data from con-
senting participants at the 3 full adherence hospitals, since pa-
tient enrollment at partial adherence hospitals was based on 
clinician suspicion. We used univariate and multivariate logistic 
regression to evaluate predictors of patients receiving a prescrip-
tion for antibiotics before blood culture results were available.
To review the effects of antimicrobial nonsusceptibility on 
treatment coverage, we analyzed the susceptibility patterns of 
confirmed enteric fever cases compared with antibiotics pre-
scribed before and after blood culture results were available at 
both full and partial adherence hospitals (Figure  1). We per-
formed this analysis using χ2 tests grouped by country, as hos-
pitals within each country were either in the same catchment 
area or within 25 km of each other.
All statistical tests were performed in R version 3.6.1 and 
were considered significant at P < .05.
Ethical Considerations
Study protocols were reviewed by Institutional Review Boards in 
the United States (Centers for Disease Control and Prevention), 
Bangladesh (Bangladesh Institute of Child Health Ethical Review 
Committee), Nepal (Nepal Health Research Council Ethical 
Review Board Approval), and Pakistan (National Bioethics 
Committee), in addition to local hospital ethical review boards.
RESULTS
During the study period, 30 809 patients from all hospitals were re-
cruited at outpatient clinics. The majority were male, and the median 
age differed by country, as well as by catchment area within country 
(Table 1). Among the 20 209 recruited at hospitals with partial adher-
ence, 9790 (48%) were prescribed a blood culture by the treating phy-
sician; this differed by hospital (P < .001), with the lowest proportion 
over the study period at Aga Khan University Hospital (40%).
At all three partial adherence hospitals, the probability of 
being prescribed a blood culture varied with age (Figure 2). At 
Shishu Sasthya Foundation Hospital, the probability was highest 
at 5 years old, and remained relatively constant until 15 years, 
but at Aga Khan University Hospital and Kharadar General 
Hospital, the probability was highest between 10 and 15 years. 
There was no difference in receiving a blood culture at Aga 
Khan University Hospital and Kharadar General Hospital com-
paring males with females, but at Shishu Sasthya Foundation 
Hospital, males had 10% higher odds (95% CI, 3%–19%).
Physicians’ practice for prescribing blood cultures based on 
the burden of febrile illness at outpatient wards also varied by 
hospital (Figure 3). At Kharadar General Hospital, the propor-
tion of febrile outpatients prescribed a blood culture was not 
significantly predicted by the number of febrile cases in the 
same month (mean change per 100 cases, .14 [95% CI, −.04–
.32]). However, when compared with the number of febrile 
cases in the previous 1–5 months, case counts from 3 months 
prior had the strongest association, with a 31% mean increase 
(95% CI, .20–.43) in the proportion prescribed a blood cul-
ture per increase in 100 febrile cases. At Aga Khan University 
Hospital, the association was negative; an increase of 100 fe-
brile cases predicted a 19% decrease (95% CI, −.24–−.15) in 
the proportion prescribed a blood culture, and the association 
Figure 2. Probability of receiving a prescription for blood culture, by age in years and site, (SEAP)—Partial adherence* hospitals in Bangladesh and Pakistan, April 2017–
March 2019. *Hospitals where physicians prescribed a blood culture based only on clinical suspicion and did not fully adhere to the SEAP recruitment protocol of prescribing 
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was weaker compared with case counts from the previous 
1–5 months. At Shishu Sasthya Foundation Hospital, increases 
in the number of cases in the same month or the previous 
1–5 months did not predict an increase or decrease in the pro-
portion prescribed a blood culture. We also did not observe 
seasonal patterns in physicians prescribing blood culture for 
febrile illness.
Among the 10 600 outpatients recruited at full adherence 
hospitals, 8019 (76%) were enrolled, had blood collected, and 
had available blood culture date data. Among those, 6355 (79%) 
were prescribed antibiotics empirically. Patient sex did not pre-
dict receiving antibiotics empirically, but older participants had 
slightly higher odds when adjusted for site (OR [age in years] 
1.01, 95% CI, 1.005–1.014). Patients with female heads of the 
household with postsecondary education had significantly lower 
odds of receiving antibiotics empirically compared with no ed-
ucation, while patients who reported taking antibiotics previ-
ously and were febrile at presentation had significantly higher 
odds. Patients provisionally diagnosed with fever of unknown 
origin or viral fever had significantly lower odds of receiving 
antibiotics empirically, while patients provisionally diagnosed 
with enteric fever, lower respiratory tract infection, and urinary 
tract infection had significantly higher odds. Notably, patients 
provisionally diagnosed with upper respiratory tract infection 
had the highest independent odds of receiving empiric anti-
biotics empirically among diagnoses examined (OR 5.26, 95% 
CI, 2.97–10.2) (Table 2).
The choice of antibiotic class given before and after avail-
able blood culture results differed among the 3 full adherence 
hospitals (Figure  4). At Kathmandu Medical College and 
Teaching Hospital, 59% of febrile outpatients received anti-
biotics empirically, compared with 86% at Dhaka Shishu 
Hospital and 83% at Dhulikhel Hospital. Among those who re-
ceived antibiotics empirically, 72% received cephalosporins at 
Dhaka Shishu Hospital, while at Dhulikhel Hospital most pa-
tients received a combination of 2 or more drugs (37%) or ceph-
alosporin monotherapy (32%). At Kathmandu Medical College 
and Teaching Hospital, 34% empirically treated patients re-
ceived cephalosporins, followed by macrolides (23%) and peni-
cillin (22%). After blood culture results were available, 196/883 
(22%) patients positive for any pathogen and 100/7136 (1.4%) 
of patients with negative blood cultures received additional 
antibiotics. At Dhaka Shishu Hospital, most blood culture pos-
itive patients with no antibiotics prescribed empirically were 
switched to cephalosporin therapy. This resulted in 82% of pos-
itive patients and 63% of all patients prescribed cephalosporins 
after available blood culture results. At Dhulikhel Hospital, 
combinations of 2 or more drugs were the most common (51%) 
treatment regimen for patients with positive blood cultures, fol-
lowed by cephalosporin monotherapy (28%). At Kathmandu 
Medical College and Teaching Hospital, a variety of antibiotics 
were prescribed for patients with positive blood cultures, with 
cephalosporins representing the most prevalent class (34%), 
followed by a combination (21%).
The six hospitals and all recruitment locations had a total 
of 3754 enteric fever cases. Of all enteric fever cases, 2967 
(79%) received antibiotics empirically, and among those, 569 
(19%) were prescribed an antibiotic that the strain they were 
Figure 3. Proportion of febrile outpatients prescribed a blood culture predicted by total number of febrile outpatients in the same month and 1–5 months ago, (SEAP)—
Partial adherence* hospitals in Bangladesh and Pakistan, April 2017–March 2019. *Hospitals where physicians only prescribed a blood culture based on clinical suspicion 
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infected with tested nonsusceptible (Figure 5). This varied by 
country (Bangladesh: 8%, Nepal: 11%, Pakistan: 48%, P < .001). 
However, 209 (37%) of those were still covered because multiple 
antibiotics were empirically prescribed. Among the 1147 (31%) 
not covered by initial therapy because antibiotics had not been 
empirically prescribed (n = 787), or with discordant therapy 
due to nonsusceptibility (n = 360), 544 (47%) had antibiotics 
added, which also varied significantly by country (Bangladesh: 
48%, Nepal: 73%, Pakistan: 42%, P < .001). This ultimately re-
sulted in a total of 20% of all enteric fever cases without antibiotic 
coverage: 9% because no antibiotics were prescribed, and 11% 
because the discordant therapy was not changed (Bangladesh: 
8%/6%, Nepal: 7%/3%, Pakistan: 13%/23%, P < .001).
DISCUSSION
Our data revealed that clinical decision-making, both in the uti-
lization of blood cultures for diagnosis and antimicrobial treat-
ment of potential blood stream infections, may not be reflective 
of epidemiologic and microbiologic data made available by 
cultures. This is shown in the varying patterns of changes in 
physicians’ clinical decision-making in ordering blood cultures 
based on hospital-level burden data. Blood cultures were also 
differentially utilized based on age, with the probability of re-
ceiving a blood culture not reflective of recent age-stratified 
burden estimates for enteric fever in Bangladesh and Pakistan, 
generated by SEAP (unpublished). Additionally, while results 
from blood cultures may drive changes in patient therapy, broad 
spectrum antibiotics were utilized most often, even after mi-
crobial confirmation from blood culture. Yet, antibiotics pre-
scribed empirically did not always provide robust coverage 
of bacteremic patients, especially in outbreak situations with 
transmission of resistant pathogen strains.
While blood cultures remain the primary method and cur-
rent standard for diagnosing bloodstream infections, this test 
is utilized less in South Asian settings for suspected blood 
stream infections than recommended in clinical guidelines in 
Table 2. Independent Predictors of Febrile Patients Receiving Antibiotics Prior to Available Blood Culture Results, Surveillance for Enteric Fever in Asia 
Project (SEAP) —Full Adherencee Hospitals in Bangladesh and Nepal, April 2017–March 2019
No Empiric
Antibiotics Prescribed
n = 1664 (%)
Empiric
Antibiotics Prescribed
n = 6355 (%)
Unadjusted OR 
(95% CI)
Adjusted OR  
(95% CI)
Demographics
Age in years, median (IQR) 8 (3–21) 5 (2–13) .989 (.986–.993) 1.01 (1.005–1.014)a
Male sex 950 (57) 3534 (56) .94 (.84–1.05) 1.00 (.89–1.12)a
Education level of female head of household n = 804 n = 3271   
 None 166 (21) 710 (22) Ref. Ref.
 Primary 275 (34) 1279 (39) 1.09 (.88–1.34) .92 (.73–1.16)a
 Secondary 182 (23) 678 (21) .87 (.69–1.1) .94 (.73–1.21)a
 Postsecondary 181 (23) 604 (19) .78 (.62–.99) .69 (.54–.89)a
Severity
Days to seek care, median (IQR) n = 1659, 3 (2–5) n = 6344, 4 (3–5) .99 (.97–1) .99 (.96–1.01)b
Previous antibiotics taken 438/1640 (27) 2240/6221 (36) 1.54 (1.37–1.74) 1.55 (1.29–1.87)b
Days unable to perform usual activities, 
median (IQR)
n = 1659, 3 (.5–4) n = 6338, 2 (0–4) .97 (.95–.98) 1.00 (.98–1.03)b
Febrile at presentation (≥99.5°F) 391/1662 (24) 2223 (35) 1.75 (1.55–1.98) 1.52 (1.26–1.83)b
Admitted 55/1662 (3) 448/6352 (7) 2.22 (1.68–2.98) 2.69 (1.73–4.35)c
Provisional diagnosisd, (row%)
Enteric fever 439 (12) 3363 (88) 3.13 (2.78–3.53) 2.01 (1.59–2.54)c
LRTI 28 (5) 564 (95) 5.68 (3.95–8.53) 1.63 (1.23–2.18)c
URTI 177 (14) 1065 (86) 1.69 (1.43–2.01) 5.26 (2.97–10.2)c
Fever of unknown origin 180 (40) 269 (60) .36 (.3–.44) .59 (.42–.83)c
UTI 40 (12) 299 (88) 2 (1.45–2.84) 2.51 (1.41–4.8)c
Viral fever 286 (48) 307 (52) .24 (.21–.29) .22 (.17–.29)c
Site, (row%)
 Dhaka Shishu Hospital 680 (14) 4074 (86) Ref. Ref.
 Dhulikhel Hospital 244 (17) 1204 (83) .82 (.7–.97) .65 (.47–.89)c
 Kathmandu Medical College and Teaching 
Hospital
740 (41) 1077 (59) .24 (.21–.27) .24 (.18–.31)c
aAdjusted for site.
bAdjusted for site, demographics, and severity markers (except admission status).
cAdjusted for site, demographics, severity markers, and other diagnoses.
dReference categories for diagnoses are absence of diagnosis of interest.
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high-income countries [24]; less than half of cases with 3 days 
of fever received a blood culture at hospitals with partial ad-
herence, which may still be higher than the usual proportion 
without study protocols in place. 
We also found 3 different scenarios at the partial adherence 
hospitals of how physicians responded to the burden of febrile di-
sease. At Aga Khan University Hospital in Pakistan, we found that 
as the number of febrile cases increased, the proportion of these 
cases prescribed blood culture decreased and this association was 
strongest in the same month; this would suggest that any burden 
data may not be affecting diagnostic decision-making and any in-
crease in febrile cases may be suspected to be nonbacteremic ill-
ness. At Shishu Sasthya Foundation Hospital in Bangladesh, we 
found no association between increases in febrile cases and the 
proportion prescribed blood culture. While viral fever outbreaks 
are common [25, 26], enteric fever accounted for 63% of blood 
cultures in one study in Dhaka [27], so enteric fever may be com-
monly suspected regardless of any changes to the burden of febrile 
cases. At Kharadar General Hospital in Pakistan, the epicenter of 
an XDR typhoid outbreak in Karachi, we found that febrile burden 
data from 3 months prior most strongly predicted changes in the 
proportion of febrile cases prescribed blood culture.
Our study also demonstrated a wide range of clinical prac-
tice in the choice to prescribe empiric antibiotics and the anti-
biotic regimens chosen prior to the availability of blood culture 
data. Such diversity of practice was seen even within the same 
country. Empiric treatment choices were typically driven by 
clinical suspicion, however recent data demonstrates that clin-
ical diagnoses of febrile syndromes have low positive predic-
tive value [28]. We noted that patients that reported previously 
taking antibiotics were more likely to receive antibiotics empir-
ically while patients from more educated households were less 
likely, potentially reflecting healthcare-seeking behavior by ed-
ucation of household; another analysis of SEAP data notes that 
patients from poorer households initially sought care for febrile 
illness from pharmacies [22]. In this study, most febrile patients 
were empirically treated with third-generation cephalosporins, 
and, after blood culture and sensitivity data became available, 
a further proportion were prescribed a third-generation ceph-
alosporin or a combination of antibiotics. Initiatives to tailor 
antibiotics using results from antimicrobial susceptibility pat-
terns, rather than maintaining or broadening treatment in these 
scenarios, might help improve patient outcomes [29, 30], but 
are difficult considering the scope of resistance among enteric 
Figure 4. Antibiotics classes prescribed before and after results available from blood culture, by blood culture status and hospital (SEAP)—Full adherence‡ hospitals in 
Bangladesh and Nepal, April 2017–March 2019. ‡ Hospitals where physicians prescribed a blood culture to all patients with fever for 3 or more days and residence within 
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fever, which has left few oral antibiotics available for treatment. 
Disadvantages in using broad-spectrum antibiotics compared 
to narrow-spectrum have been shown, such as selection for re-
sistant bacteria and harmful effects to the microbiome, which 
are especially disruptive during childhood [31].
For patient-level clinical decisions, we demonstrated that 
while blood culture results can help improve the proportion 
of culture-confirmed enteric fever patients with treatment 
coverage, many without an effective empiric regimen are still 
not prescribed an antimicrobial agent that matches culture 
results, despite the available blood culture and susceptibility 
testing results. There are several possible reasons why this gap 
in care exists: clinicians not following up with laboratory data; 
outpatients not available or not returning to hospital for their 
laboratory results; physicians not changing treatment choices 
due to clinical improvement; or system-wide processes that 
Figure 5. Changes to treatment after results of blood culture and antimicrobial sensitivity testing among participants with Salmonella Typhi and Paratyphi A isolated, by 
country, (SEAP)—Bangladesh, Nepal and Pakistan, April 2017–March 2019. Note: This alluvial diagram depicts all enteric fever cases stratified by country and how treatment 
was modified based on blood culture results. The colors originate at the first stage, where patients were categorized based on their isolate’s susceptibility pattern to anti-
biotics prescribed empirically, if any. Based on the antibiotic, whether multiple antibiotics were prescribed empirically, and isolate susceptibility, the second stage stratifies 
patient as covered or not covered by initial therapy. The third stage depicts whether patients were prescribed additional antibiotics based on their initial therapy coverage, 
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hinder communication between the laboratory, physicians, and 
patients. This gap in care can lead to delays in initiating appro-
priate antimicrobial therapy for bloodstream infections, which 
have been shown to be associated with greater morbidity and 
mortality [32–34]. This association has been further demon-
strated with SEAP data, where patients with a longer duration 
between symptom onset to healthcare presentation, and patients 
with XDR typhoid, were more likely to be hospitalized [35]. 
While the case fatality rate in the SEAP study was low [35], the 
study population resided within endemic areas and may have 
more immunity resulting from previous exposures; improving 
gaps in care such as the ones elicited in this study could be im-
portant for outbreak situations in nonendemic areas.
There were several limitations to our analysis. As the data were 
a secondary analysis within the SEAP study, we were only able to 
review febrile cases that resided within the study-specified hos-
pital catchment area, which may represent a less severe population 
than all febrile cases presenting to the hospital, or those who had 3 
or more days of fever, which may represent a more severe popula-
tion. It is unclear how this inclusion criteria may have affected our 
estimates, but should be considered in the interpretation of the 
study population. We were also only able to review associations 
between number of febrile cases and proportion prescribed blood 
culture aggregated by month, which is likely not representative of 
individual-level decision-making and the variety of factors that go 
into individual patient care. This is especially true considering we 
did not have wealth, severity, or clinical suspicion data on those 
not prescribed a blood culture. Another limitation of our anal-
ysis is that treatment was ascertained via chart review and some 
prescriptions could be missing from the charts and not included 
in our analysis, lowering the proportion of enteric fever cases re-
ported as covered with an appropriate antibiotic. However, SEAP 
staff routinely performed quality control and assurance on all clin-
ical information, including types and dates of prescription, and 
this would not affect the proportional breakdown of medications 
prescribed.
CONCLUSIONS
These data demonstrate that blood culture diagnostics have 
the potential to improve the clinical management of patients 
with febrile illness in South Asian settings, but reaching this 
goal may require more than just performing a blood culture 
test. A  productive area for potential improvements in patient 
care could be efforts to understand factors driving clinical de-
cision-making, especially during outbreaks of pathogens with 
antimicrobial resistance, as appropriate response to hospital-
level burden information may impact patient-care decisions. 
Even though the hospitals participating in the study had strong 
laboratory capacity, the processes to inform treating physicians 
were less operationalized in all of these settings. Optimizing 
communication strategies, as well as developing a systems 
approach to facilitate better coordination, could also contribute 
to this. As seen with our data, blood culture and antimicrobial 
susceptibility testing can help to ensure those with bacteremia 
are treated with an appropriate antimicrobial regimen in a 
timely manner. Future efforts to establish a low-cost, rapid test 
with high sensitivity and specificity are needed to contribute 
to the appropriate narrowing of the antimicrobial spectrum. 
Considering the increasing antimicrobial resistance in these 
settings, blood culture should be utilized more effectively in the 
present to guide clinical practice, especially where laboratory 
capacity is already established.
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